Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR

Journal of Clinical Microbiology

Volumn 43, Issue 12, 2005, Pages 6015-6019

  Kocagoz, Tanil ^a   Saribas, Zeynep ^b   Alp, Alpaslan ^b  

^a YEDITEPE UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RIFABUTIN; RIFALAZIL; RIFAMPICIN; RIFAPENTINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CODON; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE PROBE; HUMAN; HYBRIDIZATION; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RPOB GENE; SENSITIVITY AND SPECIFICITY;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; RIFAMPIN; TIME FACTORS; TRANSITION TEMPERATURE; TUBERCULOSIS, PULMONARY;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 30744446268     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.12.6015-6019.2005     Document Type: Article

References (25)

1. Bernard, P. S., A. Reiser, and G. H. Pritham. 2001. Mutation detection by fluorescent hybridization probe melting curves, p. 11-19. In S. Meuer, C. Wittwer, and K. Nakagawara (ed.), Rapid cycle real-time PCR, methods and applications. Springer, Heidelberg, Germany.
2. Blanchard, J. S. 1996. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu. Rev. Biochem. 65:215-239.
3. Chaisson, R. E. 2003. Treatment of chronic infections with rifamycins: is resistance likely to follow? Antimicrob. Agents Chemother. 47:3037-3039.
4. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Globel burden of tuberculosis. Estimated incidence, prevalence, and mortality by country. JAMA 282:677-686.
5. Espinal, M. A. 2003. The global situation of MDR-TB. Tuberculosis 83:44-51.
6. Heifets, L., T. Sanchez, J. Vanderkolk, and V. Pham. 1999. Development of rifapentine susceptibility tests for Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:25-28.
7. Heifets, L. B., P. J. Lindholm-Levy, and M. D. Iseman. 1988. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 137:719-721.
8. Heifets, L. B., P. J. Lindholm-Levy, and M. A. Flory. 1990. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 141:626-630.
9. Inderlied, C. B. 1991. Antimycobacterial agents: in vitro susceptibility testing, spectrums of activity, mechanisms of action and resistance, and assays for activity in biological fluids, p. 134-197. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
10. Kocagoz, T., E. Yilmaz, S. Ozkara, S. Kocagoz, M. Hayran, M. Sachedeva, and H. F. Chambers. 1993. Detection of Mycobacterium tuberculosis in sputum samples by polymerase chain reaction using a simplified procedure. J. Clin. Microbiol. 31:1435-1438.
11. Landt, O. 2001. Selection of hybridization probes for real-time quantification and genetic analysis, p. 35-41. In S. Meuer, C. Wittwer, and K. Nakagawara (ed.), Rapid cycle real-time PCR. methods and applications. Springer, Heidelberg, Germany.
12. Luna-Herrera, J., M. V. Reddy, and P. R. Gangadharam. 1995. In-vitro and intracellular activity of rifabutin on drug susceptible and multiple drug-resistant (MDR) tubercle bacilli. J. Antimicrob. Chemother. 36:355-363.
13. Moghazeh, S. L., X. Pan, T. Arain, C. D. Stover, J. M. Musser, and B. N. Kreiswirth. 1996. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob. Agents Chemother. 40:2655-2657.
14. Nachamkin, I., C. Kang, and M. P. Weinstein. 1997. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin. Infect. Dis. 24:894-900.
15. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
16. Saribas, Z., T. Kocagoz, A. Alp, and A. Gunalp. 2003. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates. J. Clin. Microbiol. 41:816-818.
17. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
18. Torres, M. J., A. Criado, J. C. Palomares, and J. Aznar. 2000. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J. Clin. Microbiol. 38:3194-3199.
19. Torres, M. J., A. Criado, M. Ruiz, A. C. Llanos, J. C. Palomares, and J. Aznar. 2003. Improved real-time PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Diagn. Microhiol. Infect. Dis. 45:207-212.
20. Uzun, M., Z. Erturan, and O. Ang. 2002. Investigation of cross-resistance between rifampin and rifabutin in Mycobacterium tuberculosis complex strains. Int. J. Tuberc. Lung Dis. 6:164-165.
21. Viedma, D. G., M. S. D. Infantes, F. Lasala, F. Chaves, L. Alcala, and E. Bouza. 2002. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J. Clin. Microbiol. 40:988-995.
22. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
23. Williams, D. L., L. Spring, L. Collins, L. P. Miller, L. B. Heifets, P. R. J. Gangadharam, and T. P. Gillis. 1998. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chcmother. 42:1853-1857.
24. Wittwer, C. 2001. Rapid cycle real-time PCR: methods and applications, p. 1-8. In S. Meuer, C. Wittwer, and K. Nakagawara (ed.), Rapid cycle real-time PCR, methods and applications. Springer, Heidelberg, Germany.
25. Yang, B., H. Koga, H. Ohno, K. Ogawa, M. Fukuda, Y. Hirata, S. Maesaki, K. Tomono, T. Tashiro, and S. Kohno. 1998. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 42:621-628.